{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T20:17:28Z","timestamp":1793132248116,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,25]],"date-time":"2021-09-25T00:00:00Z","timestamp":1632528000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,25]],"date-time":"2021-09-25T00:00:00Z","timestamp":1632528000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Dystrophinopathy, a common neuromuscular disorder, includes Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD). Many researches are currently ongoing to develop curative approaches, which results in an urgent need for biomarkers of disease progression and treatment response. This study investigated whether the serum creatinine (SCRN) level can be used as a biomarker of disease progression in dystrophinopathy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We enrolled 377 male patients with dystrophinopathy and 520 male non-dystrophinopathy controls in a cross-sectional study. From this cohort, 113 follow-up patients were enrolled in a longitudinal study. Patients\u2019 demographic information, motor function, muscle fatty infiltration, and muscle dystrophin levels were evaluated. We investigated correlations between these parameters and SCRN levels, and determined changes in SCRN levels with maturation and with motor function changes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Our results showed SCRN levels correlated with motor function (FDR\u2009&lt;\u20090.001) and timed test results (FDR between &lt;\u20090.001\u20130.012), as well as with muscle fatty infiltration (FDR\u2009&lt;\u20090.001) and dystrophin levels (FDR\u2009=\u20090.015 and 0.001). SCRN levels increased with maturation in control individuals; it slowly increased with maturation in patients with BMD but decreased generally with maturation in patients with DMD. The longitudinal study further demonstrated that SCRN levels were associated with motor function.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>These findings indicated that the SCRN level is a promising biomarker for assessing disease progression in dystrophinopathy and could be used as a potential outcome measure in clinical trials.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12883-021-02382-7","type":"journal-article","created":{"date-parts":[[2021,9,25]],"date-time":"2021-09-25T07:02:36Z","timestamp":1632553356000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Serum creatinine as a biomarker for dystrophinopathy: a cross-sectional and longitudinal study"],"prefix":"10.1186","volume":"21","author":[{"given":"Liang","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingyin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinning","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuling","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruojie","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinfu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huili","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyu","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,25]]},"reference":[{"issue":"3","key":"2382_CR1","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.ncl.2014.05.002","volume":"32","author":"KM Flanigan","year":"2014","unstructured":"Flanigan KM. Duchenne and Becker muscular dystrophies. Neurol Clin. 2014;32(3):671\u201388. https:\/\/doi.org\/10.1016\/j.ncl.2014.05.002.","journal-title":"Neurol Clin"},{"issue":"11","key":"2382_CR2","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1113\/expphysiol.2010.053025","volume":"96","author":"RJ Fairclough","year":"2011","unstructured":"Fairclough RJ, Bareja A, Davies KE. Progress in therapy for Duchenne muscular dystrophy. Exp Physiol. 2011;96(11):1101\u20133. https:\/\/doi.org\/10.1113\/expphysiol.2010.053025.","journal-title":"Exp Physiol"},{"issue":"4","key":"2382_CR3","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1002\/mus.880170405","volume":"17","author":"C Angelini","year":"1994","unstructured":"Angelini C, Pegoraro E, Turella E, Intino MT, Pini A, Costa C. Deflazacort in Duchenne dystrophy: study of long-term effect. Muscle Nerve. 1994;17(4):386\u201391. https:\/\/doi.org\/10.1002\/mus.880170405.","journal-title":"Muscle Nerve"},{"issue":"1","key":"2382_CR4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12014-016-9109-x","volume":"13","author":"Y Hathout","year":"2016","unstructured":"Hathout Y, Seol H, Han MH, Zhang A, Brown KJ, Hoffman EP. Clinical utility of serum biomarkers in Duchenne muscular dystrophy. Clin Proteomics. 2016;13(1):9. https:\/\/doi.org\/10.1186\/s12014-016-9109-x.","journal-title":"Clin Proteomics"},{"issue":"6","key":"2382_CR5","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.nmd.2014.03.007","volume":"24","author":"SD Wilton","year":"2014","unstructured":"Wilton SD, Fletcher S, Flanigan KM. Dystrophin as a therapeutic biomarker: are we ignoring data from the past? Neuromuscul Disord. 2014;24(6):463\u20136. https:\/\/doi.org\/10.1016\/j.nmd.2014.03.007.","journal-title":"Neuromuscul Disord"},{"issue":"7","key":"2382_CR6","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.nmd.2016.04.009","volume":"26","author":"D Fischer","year":"2016","unstructured":"Fischer D, Hafner P, Rubino D, Schmid M, Neuhaus C, Jung H, et al. The 6-minute walk test, motor function measure and quantitative thigh muscle MRI in Becker muscular dystrophy: a cross-sectional study. Neuromuscul Disord. 2016;26(7):414\u201322. https:\/\/doi.org\/10.1016\/j.nmd.2016.04.009.","journal-title":"Neuromuscul Disord"},{"issue":"8","key":"2382_CR7","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.nmd.2014.03.006","volume":"24","author":"A Aartsma-Rus","year":"2014","unstructured":"Aartsma-Rus A, Ferlini A, Vroom E. Biomarkers and surrogate endpoints in Duchenne: meeting report. Neuromuscul Disord. 2014;24(8):743\u20135. https:\/\/doi.org\/10.1016\/j.nmd.2014.03.006.","journal-title":"Neuromuscul Disord"},{"issue":"5","key":"2382_CR8","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.nmd.2015.01.010","volume":"25","author":"A Zocevic","year":"2015","unstructured":"Zocevic A, Rouillon J, Wong B, Servais L, Voit T, Svinartchouk F. Evaluation of the serum matrix metalloproteinase-9 as a biomarker for monitoring disease progression in Duchenne muscular dystrophy. Neuromuscul Disord. 2015;25(5):444\u20136. https:\/\/doi.org\/10.1016\/j.nmd.2015.01.010.","journal-title":"Neuromuscul Disord"},{"key":"2382_CR9","doi-asserted-by":"publisher","first-page":"196","DOI":"10.3389\/fneur.2017.00196","volume":"8","author":"L Wang","year":"2017","unstructured":"Wang L, Chen M, He R, Sun Y, Yang J, Xiao L, et al. Serum creatinine distinguishes Duchenne muscular dystrophy from Becker muscular dystrophy in patients aged <=3 years: a retrospective study. Front Neurol. 2017;8:196. https:\/\/doi.org\/10.3389\/fneur.2017.00196.","journal-title":"Front Neurol"},{"key":"2382_CR10","doi-asserted-by":"publisher","first-page":"141856","DOI":"10.1155\/2015\/141856","volume":"2015","author":"H Zhang","year":"2015","unstructured":"Zhang H, Zhu Y, Sun Y, Liang Y, Li Y, Zhang Y, et al. Serum creatinine level: a supplemental index to distinguish Duchenne muscular dystrophy from Becker muscular dystrophy. Dis Markers. 2015;2015:141856\u20135. https:\/\/doi.org\/10.1155\/2015\/141856.","journal-title":"Dis Markers"},{"key":"2382_CR11","doi-asserted-by":"publisher","first-page":"S36","DOI":"10.1016\/j.nmd.2018.06.046","volume":"28","author":"L Wang","year":"2018","unstructured":"Wang L, Xu M, Li H, Zhang C. Reasons for first visit to neurologists in Chinese patients with dystrophinopathy: a survey study. Neuromuscul Disord. 2018;28:S36\u20137. https:\/\/doi.org\/10.1016\/j.nmd.2018.06.046.","journal-title":"Neuromuscul Disord"},{"issue":"6","key":"2382_CR12","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.nmd.2014.03.008","volume":"24","author":"JK Mah","year":"2014","unstructured":"Mah JK, Korngut L, Dykeman J, Day L, Pringsheim T, Jette N. A systematic review and meta-analysis on the epidemiology of Duchenne and Becker muscular dystrophy. Neuromuscul Disord. 2014;24(6):482\u201391. https:\/\/doi.org\/10.1016\/j.nmd.2014.03.008.","journal-title":"Neuromuscul Disord"},{"issue":"3","key":"2382_CR13","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1007\/s00256-004-0825-3","volume":"34","author":"FA Marden","year":"2005","unstructured":"Marden FA, Connolly AM, Siegel MJ, Rubin DA. Compositional analysis of muscle in boys with Duchenne muscular dystrophy using MR imaging. Skelet Radiol. 2005;34(3):140\u20138. https:\/\/doi.org\/10.1007\/s00256-004-0825-3.","journal-title":"Skelet Radiol"},{"issue":"3","key":"2382_CR14","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1542\/peds.2014-2044","volume":"135","author":"PA Romitti","year":"2015","unstructured":"Romitti PA, Zhu Y, Puzhankara S, James KA, Nabukera SK, Zamba GK, et al. Prevalence of Duchenne and Becker muscular dystrophies in the United States. Pediatrics. 2015;135(3):513\u201321. https:\/\/doi.org\/10.1542\/peds.2014-2044.","journal-title":"Pediatrics"},{"key":"2382_CR15","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3389\/fgene.2019.00114","volume":"10","author":"L Wang","year":"2019","unstructured":"Wang L, Xu M, Li H, He R, Lin J, Zhang C, et al. Genotypes and phenotypes of DMD small mutations in Chinese patients with Dystrophinopathies. Front Genet. 2019;10:114. https:\/\/doi.org\/10.3389\/fgene.2019.00114.","journal-title":"Front Genet"},{"issue":"1","key":"2382_CR16","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1471-2350-14-29","volume":"14","author":"J Yang","year":"2013","unstructured":"Yang J, Li SY, Li YQ, Cao JQ, Feng SW, Wang YY, et al. MLPA-based genotype-phenotype analysis in 1053 Chinese patients with DMD\/BMD. BMC Med Genet. 2013;14(1):29. https:\/\/doi.org\/10.1186\/1471-2350-14-29.","journal-title":"BMC Med Genet"},{"issue":"4","key":"2382_CR17","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/mus.20812","volume":"36","author":"C Angelini","year":"2007","unstructured":"Angelini C. The role of corticosteroids in muscular dystrophy: a critical appraisal. Muscle Nerve. 2007;36(4):424\u201335. https:\/\/doi.org\/10.1002\/mus.20812.","journal-title":"Muscle Nerve"},{"issue":"1","key":"2382_CR18","doi-asserted-by":"publisher","first-page":"22","DOI":"10.5535\/arm.2012.36.1.22","volume":"36","author":"IY Jung","year":"2012","unstructured":"Jung IY, Chae JH, Park SK, Kim JH, Kim JY, Kim SJ, et al. The correlation analysis of functional factors and age with Duchenne muscular dystrophy. Ann Rehabil Med. 2012;36(1):22\u201332. https:\/\/doi.org\/10.5535\/arm.2012.36.1.22.","journal-title":"Ann Rehabil Med"},{"key":"2382_CR19","first-page":"13723","volume":"9","author":"Q Bing","year":"2016","unstructured":"Bing Q, Hu K, Tian Q, Zhao Z, Shen H, Li N, et al. Semi-quantitative assessment of lower limb MRI in dystrophinopathy. Int J Clin Exp Med. 2016;9:13723\u201332.","journal-title":"Int J Clin Exp Med"},{"issue":"8","key":"2382_CR20","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/j.jocn.2012.09.021","volume":"20","author":"SJ Na","year":"2013","unstructured":"Na SJ, Kim WJ, Kim SM, Lee KO, Yoon B, Choi YC. Clinical, immunohistochemical, Western blot, and genetic analysis in dystrophinopathy. J Clin Neurosci. 2013;20(8):1099\u2013105. https:\/\/doi.org\/10.1016\/j.jocn.2012.09.021.","journal-title":"J Clin Neurosci"},{"issue":"4","key":"2382_CR21","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1212\/WNL.0b013e318208811f","volume":"76","author":"M Kinali","year":"2011","unstructured":"Kinali M, Arechavala-Gomeza V, Cirak S, Glover A, Guglieri M, Feng L, et al. Muscle histology vs MRI in Duchenne muscular dystrophy. Neurology. 2011;76(4):346\u201353. https:\/\/doi.org\/10.1212\/WNL.0b013e318208811f.","journal-title":"Neurology."},{"issue":"4","key":"2382_CR22","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1001\/archneur.1991.00530160047012","volume":"48","author":"RC Griggs","year":"1991","unstructured":"Griggs RC, Moxley RT 3rd, Mendell JR, Fenichel GM, Brooke MH, Pestronk A, et al. Prednisone in Duchenne dystrophy. A randomized, controlled trial defining the time course and dose response. Clinical investigation of Duchenne dystrophy group. Arch Neurol. 1991;48(4):383\u20138. https:\/\/doi.org\/10.1001\/archneur.1991.00530160047012.","journal-title":"Arch Neurol"},{"key":"2382_CR23","doi-asserted-by":"publisher","first-page":"100026","DOI":"10.1016\/j.acags.2020.100026","volume":"6","author":"E Ionas","year":"2020","unstructured":"Ionas E. Partial correlations in compositional data analysis. Applied Computing and Geosciences. 2020;6:100026.","journal-title":"Applied Computing and Geosciences"},{"issue":"280","key":"2382_CR24","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1080\/01621459.1957.10501412","volume":"52","author":"DB Suits","year":"1957","unstructured":"Suits DB. Use of dummy variables in regression equations. J Am Stat Assoc. 1957;52(280):548\u201351. https:\/\/doi.org\/10.1080\/01621459.1957.10501412.","journal-title":"J Am Stat Assoc"},{"issue":"5","key":"2382_CR25","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1007\/s10157-011-0452-y","volume":"15","author":"O Uemura","year":"2011","unstructured":"Uemura O, Honda M, Matsuyama T, Ishikura K, Hataya H, Yata N, et al. Age, gender, and body length effects on reference serum creatinine levels determined by an enzymatic method in Japanese children: a multicenter study. Clin Exp Nephrol. 2011;15(5):694\u20139. https:\/\/doi.org\/10.1007\/s10157-011-0452-y.","journal-title":"Clin Exp Nephrol"},{"issue":"4","key":"2382_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0153461","volume":"11","author":"SM Boca","year":"2016","unstructured":"Boca SM, Nishida M, Harris M, Rao S, Cheema AK, Gill K, et al. Discovery of metabolic biomarkers for Duchenne muscular dystrophy within a natural history study. PLoS One. 2016;11(4):e0153461. https:\/\/doi.org\/10.1371\/journal.pone.0153461.","journal-title":"PLoS One"},{"issue":"3","key":"2382_CR27","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1152\/physrev.2000.80.3.1107","volume":"80","author":"M Wyss","year":"2000","unstructured":"Wyss M, Kaddurah-Daouk R. Creatine and creatinine metabolism. Physiol Rev. 2000;80(3):1107\u2013213. https:\/\/doi.org\/10.1152\/physrev.2000.80.3.1107.","journal-title":"Physiol Rev"},{"issue":"3","key":"2382_CR28","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1093\/ajcn\/37.3.478","volume":"37","author":"SB Heymsfield","year":"1983","unstructured":"Heymsfield SB, Arteaga C, McManus C, Smith J, Moffitt S. Measurement of muscle mass in humans: validity of the 24-hour urinary creatinine method. Am J Clin Nutr. 1983;37(3):478\u201394. https:\/\/doi.org\/10.1093\/ajcn\/37.3.478.","journal-title":"Am J Clin Nutr"},{"issue":"5","key":"2382_CR29","doi-asserted-by":"publisher","first-page":"E305","DOI":"10.21037\/jtd.2016.03.62","volume":"8","author":"C Thongprayoon","year":"2016","unstructured":"Thongprayoon C, Cheungpasitporn W, Kashani K. Serum creatinine level, a surrogate of muscle mass, predicts mortality in critically ill patients. J Thorac Dis. 2016;8(5):E305\u201311. https:\/\/doi.org\/10.21037\/jtd.2016.03.62.","journal-title":"J Thorac Dis"},{"issue":"2","key":"2382_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0148495","volume":"11","author":"SW Kim","year":"2016","unstructured":"Kim SW, Jung HW, Kim CH, Kim KI, Chin HJ, Lee H. A new equation to estimate muscle mass from creatinine and cystatin C. PLoS One. 2016;11(2):e0148495. https:\/\/doi.org\/10.1371\/journal.pone.0148495.","journal-title":"PLoS One"},{"issue":"0","key":"2382_CR31","doi-asserted-by":"publisher","first-page":"S290","DOI":"10.1007\/s00592-003-0089-8","volume":"40","author":"D Franciotta","year":"2003","unstructured":"Franciotta D, Zanardi MC, Albertotti L, Orcesi S, Berardinelli A, Pichiecchio A, et al. Measurement of skeletal muscle mass in Duchenne muscular dystrophy: use of 24-h creatinine excretion. Acta Diabetol. 2003;40(0):S290\u20132. https:\/\/doi.org\/10.1007\/s00592-003-0089-8.","journal-title":"Acta Diabetol"},{"issue":"5","key":"2382_CR32","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.nmd.2015.01.005","volume":"25","author":"E Braat","year":"2015","unstructured":"Braat E, Hoste L, De Waele L, Gheysens O, Vermeersch P, Goffin K, et al. Renal function in children and adolescents with Duchenne muscular dystrophy. Neuromuscul Disord. 2015;25(5):381\u20137. https:\/\/doi.org\/10.1016\/j.nmd.2015.01.005.","journal-title":"Neuromuscul Disord"},{"issue":"3","key":"2382_CR33","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1002\/mus.21420","volume":"40","author":"L Viollet","year":"2009","unstructured":"Viollet L, Gailey S, Thornton DJ, Friedman NR, Flanigan KM, Mahan JD, et al. Utility of cystatin C to monitor renal function in Duchenne muscular dystrophy. Muscle Nerve. 2009;40(3):438\u201342. https:\/\/doi.org\/10.1002\/mus.21420.","journal-title":"Muscle Nerve"},{"issue":"1","key":"2382_CR34","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1203\/00006450-199607000-00006","volume":"40","author":"R Hankard","year":"1996","unstructured":"Hankard R, Gottrand F, Turck D, Carpentier A, Romon M, Farriaux JP. Resting energy expenditure and energy substrate utilization in children with Duchenne muscular dystrophy. Pediatr. 1996;40(1):29\u201333. https:\/\/doi.org\/10.1203\/00006450-199607000-00006.","journal-title":"Pediatr"},{"issue":"9","key":"2382_CR35","doi-asserted-by":"publisher","first-page":"e921","DOI":"10.1212\/WNL.0000000000008762","volume":"94","author":"CRR Alves","year":"2020","unstructured":"Alves CRR, Zhang R, Johnstone AJ, Garner R, Nwe PH, Siranosian JJ, et al. Serum creatinine is a biomarker of progressive denervation in spinal muscular atrophy. Neurology. 2020;94(9):e921\u201331. https:\/\/doi.org\/10.1212\/WNL.0000000000008762.","journal-title":"Neurology."},{"issue":"4","key":"2382_CR36","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1111\/jcmm.13543","volume":"22","author":"P Spitali","year":"2018","unstructured":"Spitali P, Hettne K, Tsonaka R, Sabir E, Seyer A, Hemerik JBA, et al. Cross-sectional serum metabolomic study of multiple forms of muscular dystrophy. J Cell Mol Med. 2018;22(4):2442\u20138. https:\/\/doi.org\/10.1111\/jcmm.13543.","journal-title":"J Cell Mol Med"},{"key":"2382_CR37","doi-asserted-by":"publisher","first-page":"e89","DOI":"10.1212\/NXG.0000000000000089","volume":"2","author":"E Harris","year":"2016","unstructured":"Harris E, Bladen CL, Mayhew A, James M, Bettinson K, Moore U, et al. The Clinical Outcome Study for dysferlinopathy: An international multicenter study. Neurol Genet. 2016;2:e89.","journal-title":"Neurol Genet"},{"issue":"11","key":"2382_CR38","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1212\/WNL.0000000000000775","volume":"83","author":"I Arpan","year":"2014","unstructured":"Arpan I, Willcocks RJ, Forbes SC, Finkel RS, Lott DJ, Rooney WD, et al. Examination of effects of corticosteroids on skeletal muscles of boys with DMD using MRI and MRS. Neurology. 2014;83(11):974\u201380. https:\/\/doi.org\/10.1212\/WNL.0000000000000775.","journal-title":"Neurology"},{"issue":"3","key":"2382_CR39","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1046\/j.1365-2796.1999.00515.x","volume":"246","author":"E Andreev","year":"1999","unstructured":"Andreev E, Koopman M, Arisz L. A rise in plasma creatinine that is not a sign of renal failure: which drugs can be responsible? J Intern Med. 1999;246(3):247\u201352. https:\/\/doi.org\/10.1046\/j.1365-2796.1999.00515.x.","journal-title":"J Intern Med"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-021-02382-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-021-02382-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-021-02382-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,25]],"date-time":"2021-09-25T19:11:16Z","timestamp":1632597076000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-021-02382-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,25]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2382"],"URL":"https:\/\/doi.org\/10.1186\/s12883-021-02382-7","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,25]]},"assertion":[{"value":"23 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the \u2018ICE for Clinical Research and Animal Trials of the First Affiliated Hospital of Sun Yat-sen University\u2019, and the need for informed consent was waived by the committee. All methods were performed in accordance with the Declaration of Helsinki and the relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"372"}}